Literature DB >> 26293610

MicroRNA-142-3p and microRNA-142-5p are downregulated in hepatocellular carcinoma and exhibit synergistic effects on cell motility.

Felice Ho-Ching Tsang1, Sandy Leung-Kuen Au, Lai Wei, Dorothy Ngo-Yin Fan, Joyce Man-Fong Lee, Carmen Chak-Lui Wong, Irene Oi-Lin Ng, Chun-Ming Wong.   

Abstract

MicroRNAs (miRNAs), an important class of small non-coding RNAs, regulate gene expression at the post-transcriptional level. miRNAs are involved in a wide range of biological processes and implicated in different diseases, including cancers. In this study, miRNA profiling and qRT-PCR validation revealed that miR-142-3p and miR-142-5p were significantly downregulated in hepatocellular carcinoma (HCC) and their expression levels decreased as the disease progressed. The ectopic expression of miR-142 significantly reduced HCC cell migration and invasion. Overexpression of either miR-142-3p or miR-142-5p suppressed HCC cell migration, and overexpression of both synergistically inhibited cell migration, which indicated that miR-142-3p and miR-142-5p may cooperatively regulate cell movement. miR-142-3p and miR-142-5p, which are mature miRNAs derived from the 3'- and 5'-strands of the precursor miR-142, target distinct pools of genes because of their different seed sequences. Pathway enrichment analysis showed a strong association of the putative gene targets of miR-142-3p and miR-142-5p with several cell motility-associated pathways, including those regulating actin cytoskeleton, adherens junctions, and focal adhesion. Importantly, a number of the putative gene targets were also significantly upregulated in human HCC cells. Moreover, overexpression of miR-142 significantly abrogated stress fiber formation in HCC cells and led to cell shrinkage. This study shows that mature miR-142 pairs collaboratively regulate different components of distinct signaling cascades and therefore affects the motility of HCC cells.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26293610     DOI: 10.1007/s11684-015-0409-8

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   4.592


  22 in total

1.  KEGG: kyoto encyclopedia of genes and genomes.

Authors:  M Kanehisa; S Goto
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

3.  Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection.

Authors:  X Zhang; Z Yan; J Zhang; L Gong; W Li; J Cui; Y Liu; Z Gao; J Li; L Shen; Y Lu
Journal:  Ann Oncol       Date:  2011-02-22       Impact factor: 32.976

4.  Sequential alterations of microRNA expression in hepatocellular carcinoma development and venous metastasis.

Authors:  Chun-Ming Wong; Carmen Chak-Lui Wong; Joyce Man-Fong Lee; Dorothy Ngo-Yin Fan; Sandy Leung-Kuen Au; Irene Oi-Lin Ng
Journal:  Hepatology       Date:  2012-05       Impact factor: 17.425

5.  Mature miR-17-5p and passenger miR-17-3p induce hepatocellular carcinoma by targeting PTEN, GalNT7 and vimentin in different signal pathways.

Authors:  Sze Wan Shan; Ling Fang; Tatiana Shatseva; Zina Jeyapalan Rutnam; Xiangling Yang; William Du; Wei-Yang Lu; Jim W Xuan; Zhaoqun Deng; Burton B Yang
Journal:  J Cell Sci       Date:  2013-02-15       Impact factor: 5.285

6.  Natural selection on human microRNA binding sites inferred from SNP data.

Authors:  Kevin Chen; Nikolaus Rajewsky
Journal:  Nat Genet       Date:  2006-10-29       Impact factor: 38.330

7.  MiR-142-3p functions as a tumor suppressor by targeting CD133, ABCG2, and Lgr5 in colon cancer cells.

Authors:  Wei-Wei Shen; Zhi Zeng; Wen-Xia Zhu; Guo-Hui Fu
Journal:  J Mol Med (Berl)       Date:  2013-04-26       Impact factor: 4.599

8.  Rho-kinase 2 is frequently overexpressed in hepatocellular carcinoma and involved in tumor invasion.

Authors:  Carmen Chak-Lui Wong; Chun-Ming Wong; Edmund Kwok-Kwan Tung; Kwan Man; Irene Oi-Lin Ng
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

9.  A mammalian microRNA expression atlas based on small RNA library sequencing.

Authors:  Pablo Landgraf; Mirabela Rusu; Robert Sheridan; Alain Sewer; Nicola Iovino; Alexei Aravin; Sébastien Pfeffer; Amanda Rice; Alice O Kamphorst; Markus Landthaler; Carolina Lin; Nicholas D Socci; Leandro Hermida; Valerio Fulci; Sabina Chiaretti; Robin Foà; Julia Schliwka; Uta Fuchs; Astrid Novosel; Roman-Ulrich Müller; Bernhard Schermer; Ute Bissels; Jason Inman; Quang Phan; Minchen Chien; David B Weir; Ruchi Choksi; Gabriella De Vita; Daniela Frezzetti; Hans-Ingo Trompeter; Veit Hornung; Grace Teng; Gunther Hartmann; Miklos Palkovits; Roberto Di Lauro; Peter Wernet; Giuseppe Macino; Charles E Rogler; James W Nagle; Jingyue Ju; F Nina Papavasiliou; Thomas Benzing; Peter Lichter; Wayne Tam; Michael J Brownstein; Andreas Bosio; Arndt Borkhardt; James J Russo; Chris Sander; Mihaela Zavolan; Thomas Tuschl
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

10.  Accurate microRNA target prediction correlates with protein repression levels.

Authors:  Manolis Maragkakis; Panagiotis Alexiou; Giorgio L Papadopoulos; Martin Reczko; Theodore Dalamagas; George Giannopoulos; George Goumas; Evangelos Koukis; Kornilios Kourtis; Victor A Simossis; Praveen Sethupathy; Thanasis Vergoulis; Nectarios Koziris; Timos Sellis; Panagiotis Tsanakas; Artemis G Hatzigeorgiou
Journal:  BMC Bioinformatics       Date:  2009-09-18       Impact factor: 3.169

View more
  20 in total

1.  Identifying microRNA panels specifically associated with hepatocellular carcinoma and its different etiologies.

Authors:  Jing Shen; Abby B Siegel; Helen Remotti; Qiao Wang; Regina M Santella
Journal:  Hepatoma Res       Date:  2016-06-01

2.  MicroRNA-142-5p promotes cell growth and migration in renal cell carcinoma by targeting BTG3.

Authors:  Lingqi Liu; Shuchao Liu; Qixin Duan; Liang Chen; Tianpeng Wu; Huijun Qian; Sixing Yang; Dianqi Xin; Zhisong He; Yinglu Guo
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

3.  Assessment of MicroRNAs Associated with Tumor Purity by Random Forest Regression.

Authors:  Dong-Yeon Nam; Je-Keun Rhee
Journal:  Biology (Basel)       Date:  2022-05-21

4.  Effects of miR-132-3p on progress and epithelial mesenchymal transition of non-small cell lung cancer via regulating KLF7.

Authors:  Ning Wang; Ye Xu; Qingkui Guo; Chen Zhu; Wen Zhao; Wenliang Qian; Min Zheng
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 2.895

5.  Computational identification of microRNAs and their targets in liver cirrhosis.

Authors:  Hongbo Du; Hao Yu; Yuying Yang; Yuanyuan Song; Fei Wang; Shangheng Li; Yuyong Jiang
Journal:  Oncol Lett       Date:  2017-10-23       Impact factor: 2.967

6.  Identification of novel diagnostic and prognostic miRNA signatures in endometrial cancer.

Authors:  Muralidharan Jayaraman; Rangasudhagar Radhakrishnan; Cara A Mathews; Mingda Yan; Sanam Husain; Katherine M Moxley; Yong Sang Song; Danny N Dhanasekaran
Journal:  Genes Cancer       Date:  2017-05

7.  Knockdown of the differentially expressed gene TNFRSF12A inhibits hepatocellular carcinoma cell proliferation and migration in vitro.

Authors:  Tao Wang; Sicong Ma; Xingxing Qi; Xiaoyin Tang; Dan Cui; Zhi Wang; Jiachang Chi; Ping Li; Bo Zhai
Journal:  Mol Med Rep       Date:  2017-01-26       Impact factor: 2.952

8.  MicroRNA‑103 modulates tumor progression by targeting KLF7 in non‑small cell lung cancer.

Authors:  Ke Li; Conghu Yuan
Journal:  Int J Mol Med       Date:  2020-06-18       Impact factor: 4.101

9.  Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma.

Authors:  Julia Liep; Ergin Kilic; Hellmuth A Meyer; Jonas Busch; Klaus Jung; Anja Rabien
Journal:  PLoS One       Date:  2016-06-23       Impact factor: 3.240

10.  Overexpression of miR-142-5p inhibits the progression of nonalcoholic steatohepatitis by targeting TSLP and inhibiting JAK-STAT signaling pathway.

Authors:  Chao Zhou; Pu Wang; Lei Lei; Yi Huang; Yue Wu
Journal:  Aging (Albany NY)       Date:  2020-05-15       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.